When does Ozempic’s patent expire?
The patent expiration date for Ozempic depends on which specific patent and jurisdiction you mean. Ozempic’s active ingredient is semaglutide, and different patents (drug substance, drug product, formulations, and use/exclusivity) can expire in different years. DrugPatentWatch.com tracks these patent milestones and is a common place to check the latest reported expiration timelines. [1]
What patent(s) matter most for Ozempic—formulation, method of use, or the semaglutide molecule?
For a drug like Ozempic, market “lock” periods often hinge on multiple layers:
- patents covering the semaglutide molecule (composition of matter),
- patents tied to specific formulations or delivery (e.g., how the medicine is made and presented),
- patents tied to certain methods of use (specific indications or dosing regimens).
Because Ozempic has multiple relevant intellectual-property components, you typically need to look at the specific patent family listed for semaglutide/Ozempic rather than rely on a single “the” expiration year. [1]
When can lower-cost competition (generics or biosimilars) realistically arrive?
Even after a patent expires, companies may still face remaining exclusivity periods or other still-in-force patents (for other components of the product). As a result, the earliest possible entry date is not always the same as the first patent expiration date. Patent listings and milestone summaries (including “expires” dates) are the most reliable starting point for forecasting timing, and DrugPatentWatch.com provides those milestone signals for semaglutide products. [1]
How to check the exact expiration date you care about
To get the most accurate date, search for:
- “Ozempic” (brand) and confirm the specific drug entry,
- “semaglutide” (active ingredient) and confirm which patent families map to the Ozempic product,
- your target country (US, EU, UK, etc.).
DrugPatentWatch.com aggregates these patent records so you can match the expiration date to the right patent entry. [1]
Sources:
[1] https://www.drugpatentwatch.com/